AAAAAA
Results:
1-15
|
Results: 15
Authors:
AHMED F
VYAS V
SALEEM A
LI XG
ZAMEK R
CORNFIELD A
HALUSKA P
IBRAHIM N
RUBIN EH
GUPTA E
Citation: F. Ahmed et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC QUANTITATION OF TOTAL AND LACTONE 20(S)CAMPTOTHECIN IN PATIENTS RECEIVING ORAL 20(S)CAMPTOTHECIN, Journal of chromatography B. Biomedical sciences and applications, 707(1-2), 1998, pp. 227-233
Authors:
VERSCHRAEGEN CF
HARRIS N
STEGER M
KAVANAGH JJ
KUDELKA AP
GIOVANELLA B
GUPTA E
Citation: Cf. Verschraegen et al., PHARMACOLOGY STUDY OF MULTIPLE ORAL DOSES OF 9-NITROCAMPTOTHECIN (9NC), Annals of oncology, 9, 1998, pp. 268-268
Authors:
MOSS C
GUPTA E
Citation: C. Moss et E. Gupta, THE NIKOLSKY SIGN IN STAPHYLOCOCCAL SCALDED SKIN SYNDROME, Archives of Disease in Childhood, 79(3), 1998, pp. 290-290
Authors:
GUPTA E
COOK TJ
RUBIN EH
SINKO PJ
Citation: E. Gupta et al., CHARACTERIZATION AND IN-VITRO IN-VIVO CORRELATION OF THE INTESTINAL PERMEABILITY OF 20(S) CAMPTOTHECIN (CPT), The FASEB journal, 11(3), 1997, pp. 1737-1737
Authors:
GUPTA E
MICK R
RAMIREZ J
WANG XL
LESTINGI TM
VOKES EE
RATAIN MJ
Citation: E. Gupta et al., PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE TOPOISOMERASE INHIBITOR IRINOTECAN IN CANCER-PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1502-1510
Authors:
GUPTA E
WANG XL
RAMIREZ J
RATAIN MJ
Citation: E. Gupta et al., MODULATION OF GLUCURONIDATION OF SN-38, THE ACTIVE METABOLITE OF IRINOTECAN, BY VALPROIC ACID AND PHENOBARBITAL, Cancer chemotherapy and pharmacology, 39(5), 1997, pp. 440-444
Authors:
SALEEM A
IBRAHIM N
PATEL M
LI XG
GUPTA E
MENDOZA J
PANTAZIS P
RUBIN EH
Citation: A. Saleem et al., MECHANISMS OF RESISTANCE IN A HUMAN CELL-LINE EXPOSED TO SEQUENTIAL TOPOISOMERASE POISONING, Cancer research, 57(22), 1997, pp. 5100-5106
Authors:
MICK R
GUPTA E
VOKES EE
RATAIN MJ
Citation: R. Mick et al., LIMITED-SAMPLING MODELS FOR IRINOTECAN PHARMACOKINETICS-PHARMACODYNAMICS - PREDICTION OF BILIARY INDEX AND INTESTINAL TOXICITY, Journal of clinical oncology, 14(7), 1996, pp. 2012-2019
Authors:
GUPTA E
MICK R
WANG X
VOKES EE
RATAIN MJ
Citation: E. Gupta et al., PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) ANALYSIS OF INTESTINAL TOXICITY ASSOCIATED WITH IRINOTECAN (CPT-11) - VALIDATION OF BILIARY INDEX (BI), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 38-38
Authors:
GUPTA E
SAFA AR
WANG XL
RATAIN MJ
Citation: E. Gupta et al., PHARMACOKINETIC MODULATION OF IRINOTECAN AND METABOLITES BY CYCLOSPORINE-A, Cancer research, 56(6), 1996, pp. 1309-1314
Authors:
GUPTA E
OLOPADE OI
RATAIN MJ
MICK R
BAKER TM
BEREZIN FK
BENSON AB
DOLAN ME
Citation: E. Gupta et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF OLTIPRAZ AS A CHEMOPREVENTIVE AGENT, Clinical cancer research, 1(10), 1995, pp. 1133-1138
Authors:
GUPTA E
WIENTJES MG
AU JLS
Citation: E. Gupta et al., PENETRATION KINETICS OF 2',3'-DIDEOXYINOSINE IN DERMIS IS DESCRIBED BY THE DISTRIBUTED MODEL, Pharmaceutical research, 12(1), 1995, pp. 108-112
Authors:
ROY SK
GUPTA E
DOLAN ME
Citation: Sk. Roy et al., PHARMACOKINETICS OF O-6-BENZYLGUANINE IN RATS AND ITS METABOLISM BY RAT-LIVER MICROSOMES, Drug metabolism and disposition, 23(12), 1995, pp. 1394-1399
Authors:
GUPTA E
DOLAN ME
MICK R
WANG X
DELEON M
BAKER T
BENSON AB
RATAIN MJ
OLOPADE OI
Citation: E. Gupta et al., PHASE-I CLINICAL-EVALUATION OF OLTIPRAZ (OLT) AS A CHEMOPREVENTIVE AGENT, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 176-176
Authors:
GUPTA E
LESTINGI TM
MICK R
RAMIREZ J
VOKES EE
RATAIN MJ
Citation: E. Gupta et al., RELATIONSHIP OF CPT-11 INDUCED DIARRHEA TO GLUCURONIDATION OF ITS METABOLITE SN-38, Clinical research, 42(3), 1994, pp. 10000394-10000394
Risultati:
1-15
|